Department of Pathology

Aaron Victor, MD, PhD

Assistant Professor-Clinical

Portrait of Aaron Victor, MD, PhD
  • Office Location:
  • N350 Doan Hall
  • 410 W. 10th Ave.
  • Columbus, OH 43210

Biosketch

Aaron Victor, MD, PhD, is an Assistant Professor in the Divisions of Clinical Pathology and Molecular Pathology at The Ohio State University Wexner Medical Center and serves as Lead Physician Liaison for the James Molecular Laboratory.

Dr. Victor earned his MD and PhD through The Ohio State University Medical Scientist Training Program and completed residency and fellowship training at Cedars-Sinai Medical Center through the Physician-Scientist Training Pathway.

His practice, academic, and research interests include hematopathology, molecular diagnostics, cancer immunology, cancer genetics, clinical informatics, pathology informatics, digital pathology, and artificial intelligence. His work focuses on the application of computational methods, including machine learning-enabled image analysis, to improve diagnostic pathology and laboratory medicine.

Board Certifications

Anatomic Pathology

Hematopathology

Molecular Genetic Pathology

Academic and Medical Appointments

2025-Present Assistant Professor-Clinical, Department of Pathology, OSUWMC, Columbus, OH

Education and Training

2024-2025 Molecular Genetic Pathology, Fellowship, Cedars-Sinai Medical Center, CA

2021-2022 Hematopathology, Fellowship, Cedars-Sinai Medical Center, CA

2018-2021 Anatomic Pathology, Residency, Cedars-Sinai Medical Center, CA

2011-2016 PhD, The Ohio State University

2009-2018 MD, The Ohio State University

Selected Publications

Search in PubMed

  • Cao D, Khan Z, Li X, Saito S, Bernstein EA, Victor AR, Ahmed F, Hoshi AO, Veiras LC, Shibata T, Che M, Cai L, Temel RE, Giani JF, Luthringer DJ, Divakaruni AS, Okwan-Duodu D, Bernstein KE. Macrophage angiotensin-converting enzyme reduces atherosclerosis by increasing peroxisome proliferator-activated receptor α and fundamentally changing lipid metabolism. Cardiovasc Res. 2023 Aug 7;119(9):1825-1841. doi: 10.1093/cvr/cvad082. PMID: 37225143.
  • Yeckes AR, Victor AR, Zhu Z, Narayanan M, Srinivasan B, Bruce B, Kaye J. The Tox Gene Encodes Two Proteins with Distinct and Shared Roles in Gene Regulation. J Immunol. 2023 Jun 15;210(12):1889-1898. doi: 10.4049/jimmunol.2200659. PMID: 37115203; PMCID: PMC10247481.
  • Krishnan V, Victor AR, Bose S, Bakkar R. Lymphoid cell rich fine-needle aspirations of the salivary gland: What is the risk of malignancy? Cytojournal. 2023 May 6;20:11. doi: 10.25259/Cytojournal_4_2022. PMID: 37292122; PMCID: PMC10246398.
  • Saito S, Cao DY, Victor AR, Peng Z, Wu HY, Okwan-Duodu D. RASAL3 Is a Putative RasGAP Modulating Inflammatory Response by Neutrophils. Front Immunol. 2021 Oct 27;12:744300. doi: 10.3389/fimmu.2021.744300. PMID: 34777356; PMCID: PMC8579101.
  • Peng Z, Liu C, Victor AR, Cao DY, Veiras LC, Bernstein EA, Khan Z, Giani JF, Cui X, Bernstein KE, Okwan-Duodu D. Tumors exploit CXCR4hiCD62Llo aged neutrophils to facilitate metastatic spread. Oncoimmunology. 2021 Jan 20;10(1):1870811. doi: 10.1080/2162402X.2020.1870811. PMID: 33537175; PMCID: PMC7833766.
  • Victor AR, Weigel C, Scoville SD, Chan WK, Chatman K, Nemer MM, Mao C, Young KA, Zhang J, Yu J, Freud AG, Oakes CC, Caligiuri MA. Epigenetic and Posttranscriptional Regulation of CD16 Expression during Human NK Cell Development. J Immunol. 2018 Jan 15;200(2):565-572. doi: 10.4049/jimmunol.1701128. Epub 2017 Dec 11. PMID: 29229679; PMCID: PMC5881939.
  • Victor AR, Nalin AP, Dong W, McClory S, Wei M, Mao C, Kladney RD, Youssef Y, Chan WK, Briercheck EL, Hughes T, Scoville SD, Pitarresi JR, Chen C, Manz S, Wu LC, Zhang J, Ostrowski MC, Freud AG, Leone GW, Caligiuri MA, Yu J. IL-18 Drives ILC3 Proliferation and Promotes IL-22 Production via NF-κB. J Immunol. 2017 Oct 1;199(7):2333-2342. doi: 10.4049/jimmunol.1601554. Epub 2017 Aug 25. PMID: 28842466; PMCID: PMC5624342.
  • Han J, Chu J, Keung Chan W, Zhang J, Wang Y, Cohen JB, Victor A, Meisen WH, Kim SH, Grandi P, Wang QE, He X, Nakano I, Chiocca EA, Glorioso Iii JC, Kaur B, Caligiuri MA, Yu J. CAR-Engineered NK Cells Targeting Wild-Type EGFR and EGFRvIII Enhance Killing of Glioblastoma and Patient-Derived Glioblastoma Stem Cells. Sci Rep. 2015 Jul 9;5:11483. doi: 10.1038/srep11483. PMID: 26155832; PMCID: PMC4496728.
  • Schrock JW, Glasenapp M, Victor A, Losey T, Cydulka RK. Variables associated with discordance between emergency physician and neurologist diagnoses of transient ischemic attacks in the emergency department. Ann Emerg Med. 2012 Jan;59(1):19-26. doi: 10.1016/j.annemergmed.2011.03.009. Epub 2011 May 31. PMID: 21624703.
  • Schrock JW, Victor A, Losey T. Can the ABCD2 risk score predict positive diagnostic testing for emergency department patients admitted for transient ischemic attack? Stroke. 2009 Oct;40(10):3202-5. doi: 10.1161/STROKEAHA.109.560045. Epub 2009 Jul 23. PMID: 19628796.